Scientists hunt for genetic clues in chest cancers

NCT ID NCT00242723

Recruiting now Knowledge-focused Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 35 times

Summary

This study aims to collect tumor tissue, normal tissue, and blood samples from up to 1,559 people with cancers of the lung, esophagus, or chest lining. Researchers will analyze these samples to learn about genetic and epigenetic changes that may affect how the disease progresses. The goal is to better understand these cancers and help identify patients who might benefit from future treatments at the National Cancer Institute.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMAS NOS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CANCERS OF NON THORACIC ORIGIN WITH METASTASES TO THE LUNGS OR PLEURA CANCERS OF NON THORACIC ORIGIN WITH METASTASES TO THE LUNGS OR PLEURA ESOPHAGEAL CANCERS NOS ESOPHAGEAL CANCERS NOS LUNG CANCER NOS MALIGNANT PLEURAL MESOTHELIOMAS NOS THORACIC CANCERS